لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Kurtulus S, Sakuishi K, Ngiow SF, Joller N, Tan DJ, Teng MW, Smyth MJ, Kuchroo VK, Anderson AC

المصدر: The Journal of clinical investigation [J Clin Invest] 2024 Jul 01; Vol. 134 (13). Date of Electronic Publication: 2024 Jul 01.

نوع المنشور: Journal Article; Retraction of Publication

بيانات الدورية: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Electronic Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE

مواضيع طبية MeSH: T-Lymphocytes, Regulatory*/immunology , Receptors, Immunologic*/immunology , Receptors, Immunologic*/metabolism , Receptors, Immunologic*/genetics, Humans ; Animals ; Mice

المؤلفون: Li XY, Das I, Lepletier A, Addala V, Bald T, Stannard K, Barkauskas D, Liu J, Aguilera AR, Takeda K, Braun M, Nakamura K, Jacquelin S, Lane SW, Teng MW, Dougall WC, Smyth MJ

المصدر: The Journal of clinical investigation [J Clin Invest] 2022 Mar 15; Vol. 132 (6).

نوع المنشور: Journal Article; Retraction of Publication

بيانات الدورية: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Print Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: PubMed not MEDLINE; MEDLINE

المؤلفون: Guillerey C; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia.; School of Medicine, The University of Queensland, Herston, QLD, Australia., Stannard K; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia., Chen J; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia.; School of Medicine, The University of Queensland, Herston, QLD, Australia., Krumeich S; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia., Miles K; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia., Nakamura K; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia., Smith J; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia.; School of Environment and Sciences, Griffith University, Brisbane, QLD, Australia., Yu Y; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia., Ng S; Immunology and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia., Harjunpää H; School of Medicine, The University of Queensland, Herston, QLD, Australia.; Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia., Teng MW; Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia., Engwerda C; Immunology and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia., Belz GT; Immunology Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Melbourne, VIC, Australia., Smyth MJ; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia.; School of Medicine, The University of Queensland, Herston, QLD, Australia.

المصدر: Immunology and cell biology [Immunol Cell Biol] 2021 Jan; Vol. 99 (1), pp. 65-83. Date of Electronic Publication: 2020 Sep 18.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 8706300 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1440-1711 (Electronic) Linking ISSN: 08189641 NLM ISO Abbreviation: Immunol Cell Biol Subsets: MEDLINE

مواضيع طبية MeSH: Immunity, Innate* , Multiple Myeloma*/drug therapy, Animals ; Cytokines ; Humans ; Interleukin-33 ; Lectins, C-Type ; Lymphocytes ; Mice ; Receptors, Immunologic

المؤلفون: Jacoberger-Foissac C; QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Blake SJ; QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Liu J; QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., McDonald E; QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Triscott H; QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.; School of Medicine, University of Queensland, Herston, Queensland, Australia., Nakamura K; QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.; School of Medicine, University of Queensland, Herston, Queensland, Australia., Smyth MJ; QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.; School of Medicine, University of Queensland, Herston, Queensland, Australia., Teng MW; QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia Michele.Teng@qimrberghofer.edu.au.; School of Medicine, University of Queensland, Herston, Queensland, Australia.

المصدر: Journal for immunotherapy of cancer [J Immunother Cancer] 2020 Nov; Vol. 8 (2).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents, Immunological/*adverse effects , CD40 Antigens/*antagonists & inhibitors , Immunity/*immunology , Tumor Necrosis Factor-alpha/*antagonists & inhibitors, Animals ; Antineoplastic Agents, Immunological/pharmacology ; Antineoplastic Agents, Immunological/therapeutic use ; Female ; Humans ; Immunotherapy/methods ; Male ; Mice

المؤلفون: Guillerey C; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.; School of Medicine, The University of Queensland, Herston, Queensland, Australia.; Cancer Immunotherapies Laboratory, Mater Research Institute, The University of Queensland, Translational Research Institute, Woolloongabba, Queensland, Australia., Nakamura K; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Pichler AC; Cancer Research Center of Toulouse, INSERM UMR 1037, Toulouse, France., Barkauskas D; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Krumeich S; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Stannard K; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Miles K; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Harjunpää H; School of Medicine, The University of Queensland, Herston, Queensland, Australia.; Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Yu Y; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Casey M; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Doban AI; ASML Netherlands B.V., Veldhoven, Netherlands., Lazar M; Department of Electrical Engineering, Eindhoven University of Technology, Eindhoven, Netherlands., Hartel G; Statistics Unit and., Smith D; Statistics Unit and., Vuckovic S; Bone Marrow Transplantation Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.; Multiple Myeloma Research Group, Institute of Haematology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia., Teng MW; Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Bergsagel PL; Comprehensive Cancer Center, Mayo Clinic, Scottsdale, Arizona, USA., Chesi M; Comprehensive Cancer Center, Mayo Clinic, Scottsdale, Arizona, USA., Hill GR; Bone Marrow Transplantation Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Martinet L; Cancer Research Center of Toulouse, INSERM UMR 1037, Toulouse, France., Smyth MJ; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.; School of Medicine, The University of Queensland, Herston, Queensland, Australia.

المصدر: JCI insight [JCI Insight] 2019 Jun 13; Vol. 5. Date of Electronic Publication: 2019 Jun 13.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 101676073 Publication Model: Electronic Cited Medium: Internet ISSN: 2379-3708 (Electronic) Linking ISSN: 23793708 NLM ISO Abbreviation: JCI Insight Subsets: MEDLINE

مواضيع طبية MeSH: 4-1BB Ligand/*metabolism , Antibodies, Monoclonal/*pharmacology , Antineoplastic Agents/*pharmacology , Immunotherapy/*methods , Multiple Myeloma/*drug therapy, Animals ; Antibodies, Monoclonal/therapeutic use ; Antigens, Neoplasm/immunology ; Antineoplastic Agents/therapeutic use ; CD8-Positive T-Lymphocytes/drug effects ; CD8-Positive T-Lymphocytes/immunology ; Disease Models, Animal ; Immunologic Factors/pharmacology ; Immunologic Factors/therapeutic use ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Multiple Myeloma/pathology ; T-Lymphocytes, Regulatory

المؤلفون: Smyth MJ; Immunology in Cancer and Infection Laboratory QIMR Berghofer Medical Research Institute 300 Herston Road Herston 4006 QLD Australia., Teng MW; Cancer Immunoregulation and Immunotherapy QIMR Berghofer Medical Research Institute 300 Herston Road Herston 4006 QLD Australia.

المصدر: Clinical & translational immunology [Clin Transl Immunology] 2018 Oct 24; Vol. 7 (10), pp. e1041. Date of Electronic Publication: 2018 Oct 24 (Print Publication: 2018).

نوع المنشور: Editorial

بيانات الدورية: Publisher: John Wiley & Sons Australia, Ltd. on behalf of Australasian Society for Immunology Inc Country of Publication: Australia NLM ID: 101638268 Publication Model: eCollection Cited Medium: Print ISSN: 2050-0068 (Print) Linking ISSN: 20500068 NLM ISO Abbreviation: Clin Transl Immunology Subsets: PubMed not MEDLINE

المؤلفون: Yan J; Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, Australia.; School of Medicine, University of Queensland, Brisbane, Australia., Cua DJ; Merck Research Laboratories, Palo Alto, CA, USA., Teng MW; Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, Australia.; School of Medicine, University of Queensland, Brisbane, Australia.

المصدر: Immunology and cell biology [Immunol Cell Biol] 2018 Oct; Vol. 96 (9), pp. 883-885. Date of Electronic Publication: 2018 Sep 08.

نوع المنشور: Journal Article; Comment

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 8706300 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1440-1711 (Electronic) Linking ISSN: 08189641 NLM ISO Abbreviation: Immunol Cell Biol Subsets: MEDLINE

مواضيع طبية MeSH: Prostatic Neoplasms* , Prostatic Neoplasms, Castration-Resistant*, Cell Line, Tumor ; Humans ; Interleukin-23 ; Male ; Myeloid Cells

المؤلفون: Li XY; Immunology in Cancer and Infection Laboratory and., Das I; Immunology in Cancer and Infection Laboratory and., Lepletier A; Immunology in Cancer and Infection Laboratory and., Addala V; Medical Genomics, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Bald T; Immunology in Cancer and Infection Laboratory and., Stannard K; Immunology in Cancer and Infection Laboratory and., Barkauskas D; Immunology in Cancer and Infection Laboratory and., Liu J; Immunology in Cancer and Infection Laboratory and., Aguilera AR; Immunology in Cancer and Infection Laboratory and., Takeda K; Division of Cell Biology, Biomedical Research Center and Department of Biofunctional Microbiota, Graduate School of Medicine, Juntendo University, Tokyo, Japan., Braun M; Immunology in Cancer and Infection Laboratory and., Nakamura K; Immunology in Cancer and Infection Laboratory and., Jacquelin S; Gordon and Jessie Gilmour Leukaemia Research Laboratory, Immunology Department, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Lane SW; Gordon and Jessie Gilmour Leukaemia Research Laboratory, Immunology Department, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.; The Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.; School of Medicine, The University of Queensland, Herston, Queensland, Australia., Teng MW; School of Medicine, The University of Queensland, Herston, Queensland, Australia.; Cancer Immunoregulation and Immunotherapy and., Dougall WC; Immunology in Cancer and Infection Laboratory and.; Immuno-oncology Discovery, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Smyth MJ; Immunology in Cancer and Infection Laboratory and.; School of Medicine, The University of Queensland, Herston, Queensland, Australia.

المصدر: The Journal of clinical investigation [J Clin Invest] 2018 Jun 01; Vol. 128 (6), pp. 2613-2625. Date of Electronic Publication: 2018 May 14.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Retracted Publication

بيانات الدورية: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE

مواضيع طبية MeSH: Immunity, Cellular*, CD8-Positive T-Lymphocytes/*immunology , Killer Cells, Natural/*immunology , Neoplasm Proteins/*deficiency , Neoplasms, Experimental/*immunology , Receptors, Virus/*deficiency, Animals ; B7-H1 Antigen/genetics ; B7-H1 Antigen/immunology ; CD8-Positive T-Lymphocytes/pathology ; CTLA-4 Antigen/genetics ; CTLA-4 Antigen/immunology ; Cell Line, Tumor ; Killer Cells, Natural/pathology ; Mice ; Mice, Inbred BALB C ; Mice, Knockout ; Neoplasm Proteins/immunology ; Neoplasms, Experimental/genetics ; Neoplasms, Experimental/pathology ; Receptors, Virus/immunology

المؤلفون: Slaney CY; Cancer Immunology Program, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia. michael.kershaw@petermac.org clare.slaney@petermac.org.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia., von Scheidt B; Cancer Immunology Program, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia., Davenport AJ; Cancer Immunology Program, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia., Beavis PA; Cancer Immunology Program, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia., Westwood JA; Cancer Immunology Program, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia., Mardiana S; Cancer Immunology Program, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia., Tscharke DC; John Curtin School of Medical Research, Australian National University, Canberra, Australia., Ellis S; Cancer Immunology Program, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia., Prince HM; Cancer Immunology Program, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia., Trapani JA; Cancer Immunology Program, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia., Johnstone RW; Cancer Immunology Program, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia., Smyth MJ; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Teng MW; Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Ali A; Cancer Immunology Program, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia., Yu Z; Center for Cancer Research, National Cancer Institute, National Institute of Health, Bethesda, Maryland., Rosenberg SA; Center for Cancer Research, National Cancer Institute, National Institute of Health, Bethesda, Maryland., Restifo NP; Center for Cancer Research, National Cancer Institute, National Institute of Health, Bethesda, Maryland., Neeson P; Cancer Immunology Program, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia., Darcy PK; Cancer Immunology Program, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.; Department of Immunology, Monash University, Clayton, Australia., Kershaw MH; Cancer Immunology Program, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia. michael.kershaw@petermac.org clare.slaney@petermac.org.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.; Department of Immunology, Monash University, Clayton, Australia.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2017 May 15; Vol. 23 (10), pp. 2478-2490. Date of Electronic Publication: 2016 Dec 13.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Immunotherapy, Adoptive*, Brain Neoplasms/*therapy , Breast Neoplasms/*therapy , Receptor, ErbB-2/*immunology , gp100 Melanoma Antigen/*immunology, Animals ; Autoantigens/administration & dosage ; Autoantigens/immunology ; Brain Neoplasms/immunology ; Brain Neoplasms/pathology ; Breast Neoplasms/immunology ; CD8-Positive T-Lymphocytes/immunology ; Cancer Vaccines/administration & dosage ; Cancer Vaccines/immunology ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Female ; Flow Cytometry ; Humans ; Interferon-gamma/antagonists & inhibitors ; Interferon-gamma/immunology ; Mice ; Mice, Transgenic ; Receptor, ErbB-2/genetics ; Receptors, Antigen, T-Cell/administration & dosage ; Receptors, Antigen, T-Cell/immunology ; Remission Induction ; Vaccinia virus/genetics ; Vaccinia virus/immunology ; gp100 Melanoma Antigen/genetics